FTSE 100
|
10 402,44
|
-69,67
|
-0,67 %
|
Analysen zu FTSE 100-Werten
| 21.03.24 | Rolls-Royce Buy | Goldman Sachs Group Inc. | |
| 21.03.24 | Rolls-Royce Buy | UBS AG | |
| 21.03.24 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 19.03.24 | easyJet Overweight | JP Morgan Chase & Co. | |
| 19.03.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 19.03.24 | Diageo Outperform | Bernstein Research | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 19.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 19.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 19.03.24 | GSK Buy | UBS AG | |
| 19.03.24 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 18.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 18.03.24 | Shell Overweight | Barclays Capital | |
| 18.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 18.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 18.03.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 18.03.24 | Reckitt Benckiser Outperform | Bernstein Research | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 18.03.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 18.03.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 15.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 15.03.24 | Vodafone Group Buy | UBS AG | |
| 15.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 15.03.24 | Glencore Outperform | RBC Capital Markets | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.03.24 | Shell Neutral | UBS AG | |
| 14.03.24 | BP Buy | UBS AG | |
| 13.03.24 | BAT Neutral | UBS AG | |
| 13.03.24 | Glencore Buy | Deutsche Bank AG | |
| 12.03.24 | BAT Buy | Jefferies & Company Inc. | |
| 12.03.24 | BAT Neutral | UBS AG | |
| 11.03.24 | BAT Buy | Jefferies & Company Inc. | |
| 11.03.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 08.03.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.03.24 | GSK Buy | UBS AG | |
| 06.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 06.03.24 | International Consolidated Airlines Outperform | Bernstein Research |
HOT STOCKS DER LETZTEN 3 TAGE
| BP | 9 |
| AstraZeneca | 8 |
| Unilever | 6 |
| BAT | 3 |
| Shell | 2 |
| RELX | 1 |
| London Stock Exchange | 1 |
| International Consolidated Airlines | 1 |
| Vodafone Group | 1 |
| Rio Tinto | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.